The Law Offices of Frank R. Cruz announces that investors with losses related to Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) have opportunity to lead the securities fraud class action lawsuit.
https://mma.prnewswire.com/media/1221557/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN IOVANCE BIOTHERAPEUTICS, INC. (IOVA), CLICK HEREBEFORE JULY 14, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
What Is The Lawsuit About? The complaint filed alleges that, between May 9, 2024 and May 8, 2025, Defendants failed to disclose to investors that: (1) new Authorized Treatment Centers were experiencing longer timelines to begin treating patients with Amtagvi; (2) the Company's sales team and new ATCs were ineffective in patient identification and patient selection for Amtagvi, leading to higher patient drop-offs; (3) the foregoing dynamics led to higher costs and lower revenue because ATCs could not keep pace with manufactured product; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Contact Us To Participate or Learn More:
If you wish tolearn moreabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. The Law Offices of Frank R. Cruz, Email us at: info@frankcruzlaw.comCall us at: 310-914-5007Visit our website at: www.frankcruzlaw.comFollow us for updates on Twitter: twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, Telephone: 310-914-5007Email: fcruz@frankcruzlaw.comVisit our website at: www.frankcruzlaw.com
https://c212.net/c/img/favicon.png?sn=LA94965&sd=2025-05-23
View original content to download multimedia:https://www.prnewswire.com/news-releases/iovance-biotherapeutics-inc-iova-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302463856.html
SOURCE The Law Offices of Frank R. Cruz, Los Angeles
https://rt.newswire.ca/rt.gif?NewsItemId=LA94965&Transmission_Id=202505231200PR_NEWS_USPR_____LA94965&DateId=20250523